Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers

ConclusionsNowadays, it is widely accepted that changes in the normal gut microbiome causing dysbiosis and immune dysregulation play a role gastroesophageal cancer. Different interventions, including probiotics and prebiotics intake are being developed to improve therapeutic outcomes and mitigate toxicities associated with anticancer treatment. Further studies are required in order to introduce the microbiome among the available tools of precision medicine in the field of anticancer treatment.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research